Accounting,Algebra,Architecture and Design,Art & Design,Biology,Business & Finance,Calculus,Chemistry,Communications,Computer Science,Environmental science,Essay writing,Programming,Social Science,Statistics Hide all
Teaching Since:
Apr 2017
Last Sign in:
438 Weeks Ago, 1 Day Ago
Questions Answered:
9562
Tutorials Posted:
9559
Education
bachelor in business administration
Polytechnic State University Sanluis Jan-2006 - Nov-2010
CPA
Polytechnic State University Jan-2012 - Nov-2016
Experience
Professor
Harvard Square Academy (HS2) Mar-2012 - Present
Category > StatisticsPosted 10 Jun 2017My Price15.00
A pharmaceutical company is investigating the bioactivity of a new drug
Â
A pharmaceutical company is investigating the bioactivity of a new drug. Two dosage levels are used and the bioactivity measured in random samples as shown:
(a) Is there evidence to support the claim that higher dosage levels lead to greater bioactivity?
(b) Construct a 95% one-sided lower confidence bound on the difference in the two means.
(c) Do you have any concerns about the normality assumption in this problem?